(Q46722153)

24 December 2017

title

A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology (English)

1 reference

24 December 2017

attention deficit hyperactivity disorder

1 reference

0 references

author name string

Craig Jaffe

1

1 reference

24 December 2017

Kristen R Bush

2

1 reference

24 December 2017

Kristy Straits-Troster

3

1 reference

24 December 2017

Charles Meredith

4

1 reference

24 December 2017

Lisa Romwall

5

1 reference

24 December 2017

Gail Rosenbaum

6

1 reference

24 December 2017

Monique Cherrier

7

1 reference

24 December 2017

Andrew J Saxon

8

1 reference

24 December 2017

publication date

1 January 2005

1 reference

24 December 2017

Journal of Addictive Diseases

published in

1 reference

24 December 2017

volume

24

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

133-152

1 reference

24 December 2017

If a US drug abuse epidemic fails to include a major east coast city, can it be called an epidemic?

cites work

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Will the methamphetamine problem go away?

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Psychiatric symptoms in methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Cognitive impairment in individuals currently using methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

A comparison of patterns of methamphetamine and cocaine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Attention-deficit/hyperactivity disorder in adults: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

A twin study of the neuropsychological consequences of stimulant abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Dopamine and the origins of human intelligence

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Issues in the diagnosis of attention-deficit/hyperactivity disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Neuropsychological function in adults with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Methamphetamine and diphenhydramine effects on the rate of cognitive processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Effect of amphetamine on long-term retention of verbal material.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Methylphenidate improves Stroop naming speed, but not response interference, in children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Attention dysfunction predicts substance involvement in community youths

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Adult attention-deficit hyperactivity disorder: assessment guidelines based on clinical presentation to a specialty clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

The Brief Symptom Inventory (BSI) as an outcome measure for adult psychiatric inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Word-list generation deficits in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Cognitive performance of current methamphetamine and cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Efficacy of stimulants in adult ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

Attention-Deficit/Hyperactivity Disorder and Substance Use: Symptom Pattern and Drug Choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1300%2FJ069V24N03_11

21 January 2018

Identifiers

DOI

10.1300/J069V24N03_11

1 reference

24 December 2017

1 reference

24 December 2017